GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Anthera Pharmaceuticals ANTH · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Anthera Pharmaceuticals — daily ANTH Delayed
Market value
$1,028
Last close × shares
Volume
23.9k
Shares, 30 Oct 2026

About Anthera Pharmaceuticals

Its shares trade under the ticker ANTH. It has been listed since 2 March 2010. In the fiscal year to 31 December 2017, it reported a net loss of $16.9m. At that date it held total assets of $3.7m and shareholders' equity of −$5.5m.

Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines to treat serious and life threatening diseases. The company is headquartered in Hayward, California. The company went IPO on 2010-03-02. The firm has two Phase III product candidates, liprotamase also known as Sollpura and blisibimod. Sollpura is a non-porcine investigational Pancreatic Enzyme Replacement Therapy (PERT) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (EPI), often seen in patients with cystic fibrosis and other conditions. Blisibimod targets B-cell activating factor (BAFF), which has been shown to be elevated in a range of B-cell mediated autoimmune diseases, including systemic lupus erythematosus (SLE), or lupus, Immunoglobulin A nephropathy (IgA) nephropathy, lupus nephritis and others.

Figures and description from our data supplier, not checked against the company's own report.

More about Anthera Pharmaceuticals →

Latest on Anthera Pharmaceuticals

Our reporting

We have not reported on Anthera Pharmaceuticals yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Anthera Pharmaceuticals's ticker?

Anthera Pharmaceuticals trades as ANTH on its US listing, under ISIN US03674U3005.

What was Anthera Pharmaceuticals's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.